<body.content>
<![CDATA[ <html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii" />
<title></title>
<meta name="generator" content="RNS" />
<style type="text/css">



LINK {
 COLOR: blue
}
visited {
 COLOR: purple
}
.x {
 MARGIN: 72pt 90pt; size: 612.0pt 792.0pt
}
DIV.x {

}
P.a {
 MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
LI.a {
 MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
DIV.a {
 MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
SPAN.ap {
 FONT-FAMILY: "Calibri","sans-serif"
}
P.ar {
 MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; FONT-WEIGHT: bold
}
P.as {
 TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; FONT-WEIGHT: bold
}
P.at {
 TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
P.au {
 TEXT-ALIGN: center; MARGIN: 0cm 0cm 10pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; FONT-WEIGHT: bold
}
SPAN.al {
 FONT-FAMILY: "Calibri","sans-serif"; COLOR: black
}
P.av {
 TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
SPAN.aj {
 FONT-FAMILY: "Calibri","sans-serif"; COLOR: black
}
P.aw {
 TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
TABLE.ax {
 WIDTH: 453.8pt; BORDER-COLLAPSE: collapse; MARGIN-LEFT: -5.4pt
}
TD.ah {
 PADDING-BOTTOM: 0cm; PADDING-LEFT: 5.4pt; WIDTH: 306.45pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0cm
}
TABLE.ay {
 WIDTH: 446.55pt; BORDER-COLLAPSE: collapse
}
TD.ag {
 PADDING-BOTTOM: 0cm; PADDING-LEFT: 5.4pt; WIDTH: 118.5pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0cm
}
P.az {
 TEXT-ALIGN: right; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt
}
P.ba {
 MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; TEXT-DECORATION: underline
}
TR.ab {
 HEIGHT: 3pt
}
TD.ad {
 PADDING-BOTTOM: 0cm; PADDING-LEFT: 5.4pt; WIDTH: 306.45pt; PADDING-RIGHT: 5.4pt; HEIGHT: 3pt; PADDING-TOP: 0cm
}
TD.ac {
 PADDING-BOTTOM: 0cm; PADDING-LEFT: 5.4pt; WIDTH: 118.5pt; PADDING-RIGHT: 5.4pt; HEIGHT: 3pt; PADDING-TOP: 0cm
}
TD.z {
 PADDING-BOTTOM: 0cm; PADDING-LEFT: 5.4pt; WIDTH: 125.75pt; PADDING-RIGHT: 5.4pt; PADDING-TOP: 0cm
}


</style>
</head>
<body><div>RNS Number : 7012F</div> <div><org value="LSE:IMM" idsrc="xmltag.org" >Immupharma PLC</org></div> <div><chron>22 May 2017</chron></div> <div>&#160;</div>
<div class="x">
&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <chron>22 MAY 2017</chron>
&#160;
&#160;
&#160;
<org>ImmuPharma PLC</org>
("ImmuPharma" or the "Company")
&#160;
NOTIFICATION OF FULL YEAR RESULTS
Date: <chron>1 June 2017</chron>
<org>ImmuPharma PLC</org> (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended <chron>31 December 2016</chron> on Thursday&#160; <chron>1 June 2017</chron>.
&#160;
&#160;
-Ends-
&#160;
&#160;
&#160;
<table class="ax" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td class="ah" valign="top">
For further information please contact:
&#160;
<table class="ay" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td class="ah" valign="top">
<org>ImmuPharma plc</org> (<a href="http://www.immupharma.org">www.immupharma.org</a>)
</td>
<td class="ag" valign="top">
+ 44 (0) 20 7152 4080
</td>
</tr>
<tr>
<td class="ah" valign="top">
Tim McCarthy, Chairman
</td>
<td class="ag" valign="top">
 
</td>
</tr>
<tr>
<td class="ah" valign="top">
Lisa Baderoon, Head of Investor Relations
Twitter: @immupharma
&#160;
</td>
<td class="ag" valign="top">
+ 44 (0) 7721 413496
&#160;
&#160;
</td>
</tr>
<tr class="ab">
<td class="ad" valign="top">
 
</td>
<td class="ac" valign="top">
 
</td>
</tr>
<tr>
<td class="ah" valign="top">
&#160;
<org>Northland Capital Partners Limited</org> (Joint Broker)
Patrick Claridge, David Hignell, Corporate Finance
Rob Rees, Corporate Broking
&#160;
&#160;
</td>
<td class="ag" valign="top">
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 
+44 (0)20 3861 6625
</td>
</tr>
<tr>
<td class="ah" valign="top">
 
</td>
<td class="ag" valign="top">
 
</td>
</tr>
</tbody>
</table>

</td>
<td class="z" valign="top">
 
</td>
</tr>
</tbody>
</table>
&#160;
</div>
<div style="text-align:center;"> This information is provided by RNS</div><div style="text-align:center;">The company news service from the <org>London Stock Exchange</org></div><div>&#160;</div> END<div>&#160;</div><div>&#160;</div>NORKMGMKZLVGNZM</body>
</html>]]>
</body.content>